Prof. Dr. Med. Thomas Haak, Head Physician of Diabetes Center Mergentheim, Founder Member and Board Director of DiabetesDE (German Diabetes Aid) talks about the implementation of EyeArt AI Eye Screening system at their Diabetes Clinic and the impact it is having on their patients.
Access full article here: [ Ссылка ]
Visit [ Ссылка ] for more information about EyeArt® AI Eye Screening System.
#Eyenuk #EyeArt #AIEyeScreening #DiabeticRetinopathy
EyeArt has been cleared for sales as a Class IIa medical device by EU and as a Class 2 medical device by Health Canada. In the United States, it is limited by federal law to investigational use only.
